Tag: TCT 2025

Surmodics

Results from sex-specific analysis of Surmodics’ PROWL registry revealed

Surmodics has announced that results from a sex-specific analysis of 160 real-world acute, subacute, and chronic thrombotic limb ischaemia patients from its PROWL registry...

Interim RAPID-PE study reveals ‘excellent’ safety data in first 50 patients

Prespecified interim analysis data from the first 50 patients in RAPID-PE have demonstrated "excellent safety" and "remarkably efficient lab times" in patients receiving on-the-table...

TCT 2025: Trials find comparable outcomes for IVL alternatives in calcified...

Cutting balloon angioplasty and the use of a super-high-pressure non-compliant balloon have been shown to be non-inferior to intravascular lithotripsy (IVL) in separate randomised...